Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gately, S; Kerbel, R
   Antiangiogenic scheduling of lower dose cancer chemotherapy
   CANCER JOURNAL
   
   S. Gately e R. Kerbel, "Antiangiogenic scheduling of lower dose cancer chemotherapy", CANCER J, 7(5), 2001, pp. 427-436
2. Evans, WE; Johnson, JA
   Pharmacogenomics: The inherited basis for interindividual differences in drug response
   ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS
   
   W.E. Evans e J.A. Johnson, "Pharmacogenomics: The inherited basis for interindividual differences in drug response", ANN REV GEN, 2, 2001, pp. 9-39
3. Grimwade, D
   The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   D. Grimwade, "The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia", BEST P R C, 14(3), 2001, pp. 497-529
4. Kearney, L
   Molecular cytogenetics
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   L. Kearney, "Molecular cytogenetics", BEST P R C, 14(3), 2001, pp. 645-NIL_3
5. Dash, A; Gilliland, DG
   Molecular genetics of acute myeloid leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   A. Dash e D.G. Gilliland, "Molecular genetics of acute myeloid leukaemia", BEST P R C, 14(1), 2001, pp. 49-64
6. Langmuir, PB; Aplenc, R; Lange, BJ
   Acute myeloid leukaemia in children
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   P.B. Langmuir et al., "Acute myeloid leukaemia in children", BEST P R C, 14(1), 2001, pp. 77-93
7. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
   Developmental approaches in immunological control of acute myelogenous leukaemia
   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
   
   G.F. Torelli et al., "Developmental approaches in immunological control of acute myelogenous leukaemia", BEST P R C, 14(1), 2001, pp. 189-209
8. Dewar, C; Morriss, H
   Acute myelogenous leukaemia presenting with mid-foot pain after an inversion injury
   EMERGENCY MEDICINE JOURNAL
   
   C. Dewar e H. Morriss, "Acute myelogenous leukaemia presenting with mid-foot pain after an inversion injury", EMERG MED J, 18(2), 2001, pp. 143-144
9. Bodey, B
   Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells
   EXPERT OPINION ON BIOLOGICAL THERAPY
   
   B. Bodey, "Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells", EXPERT OP B, 1(4), 2001, pp. 603-617
10. Rousseau, RF; Bollard, CM; Heslop, HE
    Gene therapy for paediatric leukaemia
    EXPERT OPINION ON BIOLOGICAL THERAPY
    
    R.F. Rousseau et al., "Gene therapy for paediatric leukaemia", EXPERT OP B, 1(4), 2001, pp. 663-674
11. Braun, S; Harbeck, N
    Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients
    BREAST CANCER RESEARCH
    
    S. Braun e N. Harbeck, "Recent advances in technologies for the detection of occult metastatic cells in bone marrow of breast cancer patients", BREAST CA R, 3(5), 2001, pp. 285-288
12. Mardlin, P; Chessells, JM
    Childhood leukaemia: the medical cost of cure
    HOSPITAL MEDICINE
    
    P. Mardlin e J.M. Chessells, "Childhood leukaemia: the medical cost of cure", HOSP MED, 62(4), 2001, pp. 200-204
13. Makin, G; Eden, T
    The success of paediatric oncological research
    HOSPITAL MEDICINE
    
    G. Makin e T. Eden, "The success of paediatric oncological research", HOSP MED, 62(10), 2001, pp. 588-589
14. Grigg, A; Kannan, K; Schwarer, AP; Spencer, A; Szer, J
    Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation
    INTERNAL MEDICINE JOURNAL
    
    A. Grigg et al., "Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation", INTERN M J, 31(1), 2001, pp. 15-22
15. von der Weid, N
    Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study
    SWISS MEDICAL WEEKLY
    
    N. von der Weid, "Late effects in long-term survivors of ALL in childhood: experiences from the SPOG late effects study", SWISS MED W, 131(13-14), 2001, pp. 180-187
16. Boucheix, C; Rubinstein, E
    Tetraspanins
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    C. Boucheix e E. Rubinstein, "Tetraspanins", CELL MOL L, 58(9), 2001, pp. 1189-1205
17. Remberger, M; Mattsson, J; Ringden, O
    Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation
    PEDIATRIC TRANSPLANTATION
    
    M. Remberger et al., "Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation", PEDIAT TRAN, 5(4), 2001, pp. 285-292
18. Mullauer, L; Gruber, P; Sebinger, D; Buch, J; Wohlfart, S; Chott, A
    Mutations in apoptosis genes: a pathogenetic factor for human disease
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    
    L. Mullauer et al., "Mutations in apoptosis genes: a pathogenetic factor for human disease", MUT RES-R M, 488(3), 2001, pp. 211-231
19. Turner, SD; Wijnhoven, SWP; Tinwell, H; Lashford, LS; Rafferty, JA; Ashby, J; Vrieling, H; Fairbairn, LJ
    Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assay
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    
    S.D. Turner et al., "Assays to predict the genotoxicity of the chromosomal mutagen etoposide - focussing on the best assay", MUT RES-GTE, 493(1-2), 2001, pp. 139-147
20. Giver, CR; Wong, R; Moore, DH; Pallavicini, MG
    Persistence of aneuploid immature/primitive hemopoietic sub-populations inmice 8 months after benzene exposure in vivo
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    
    C.R. Giver et al., "Persistence of aneuploid immature/primitive hemopoietic sub-populations inmice 8 months after benzene exposure in vivo", MUT RES-GTE, 491(1-2), 2001, pp. 127-138
21. Uckun, FM
    Rationally designed anti-mitotic agents with pro-apoptotic activity
    CURRENT PHARMACEUTICAL DESIGN
    
    F.M. Uckun, "Rationally designed anti-mitotic agents with pro-apoptotic activity", CUR PHARM D, 7(16), 2001, pp. 1627-1639
22. Vina, I; Karsakevich, A; Bekers, M
    Stabilization of anti-leukemic enzyme L-asparaginase by immobilization on polysaccharide levan
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
    
    I. Vina et al., "Stabilization of anti-leukemic enzyme L-asparaginase by immobilization on polysaccharide levan", J MOL CAT B, 11(4-6), 2001, pp. 551-558
23. Karsila-Tenovuo, S; Jahnukainen, K; Peltomaki, T; Minn, H; Kulmala, J; Salmi, TT; Ronning, O
    Disturbances in craniofacial morphology in children treated for solid tumors
    ORAL ONCOLOGY
    
    S. Karsila-Tenovuo et al., "Disturbances in craniofacial morphology in children treated for solid tumors", ORAL ONCOL, 37(7), 2001, pp. 586-592
24. Jung, LL; Zamboni, WC
    Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?
    DRUG RESISTANCE UPDATES
    
    L.L. Jung e W.C. Zamboni, "Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?", DRUG RESIST, 4(3), 2001, pp. 152-167
25. Zumkeller, W
    IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    W. Zumkeller, "IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?", J CL PATH-M, 54(5), 2001, pp. 285-288
26. Snider, JV; Wechser, MA; Lossos, IS
    Human disease characterization: real-time quantitative PCR analysis of gene expression
    DRUG DISCOVERY TODAY
    
    J.V. Snider et al., "Human disease characterization: real-time quantitative PCR analysis of gene expression", DRUG DISC T, 6(20), 2001, pp. 1062-1067
27. Fumarola, C; Zerbini, A; Guidotti, GG
    Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis
    CELL DEATH AND DIFFERENTIATION
    
    C. Fumarola et al., "Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis", CELL DEAT D, 8(10), 2001, pp. 1004-1013
28. Shibuya, A; Ishii, S; Sasaki, N
    Successful donor lymphocyte infusion in a patient with relapse of lymphoblastic leukemia after bone marrow transplantation
    PEDIATRICS INTERNATIONAL
    
    A. Shibuya et al., "Successful donor lymphocyte infusion in a patient with relapse of lymphoblastic leukemia after bone marrow transplantation", PEDIATR INT, 43(2), 2001, pp. 169-171
29. Isobe, K; Tamaru, J; Nakamura, S; Itami, J; Aruga, T; Uno, T; Yasuda, S; Mikata, A; Ito, H
    Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression
    PATHOLOGY INTERNATIONAL
    
    K. Isobe et al., "Blastic natural killer cell lymphoma arising from the mediastinum with terminal deoxynucleotidyl transferase expression", PATHOL INT, 51(1), 2001, pp. 55-59
30. Sbaa-Ketata, E; Vasse, M; Lenormand, B; Schneider, P; Soria, C; Vannier, JP
    Fibronectin increases the migration induced by stromal cell-derived factor-1 alpha (SDF-1 alpha) in pre-B acute lymphoblastic leukemia cells
    EUROPEAN CYTOKINE NETWORK
    
    E. Sbaa-Ketata et al., "Fibronectin increases the migration induced by stromal cell-derived factor-1 alpha (SDF-1 alpha) in pre-B acute lymphoblastic leukemia cells", EUR CYTOKIN, 12(2), 2001, pp. 223-230
31. Bruserud, O; Foss, B; Petersen, H
    Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)
    EUROPEAN CYTOKINE NETWORK
    
    O. Bruserud et al., "Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)", EUR CYTOKIN, 12(2), 2001, pp. 231-238
32. Landini, I; Bartolozzi, B; Banchelli, I; Innocenti, AD; Nocentini, O; Bernabei, PA
    In vitro activity of vinorelbine on human leukemia cells
    JOURNAL OF CHEMOTHERAPY
    
    I. Landini et al., "In vitro activity of vinorelbine on human leukemia cells", J CHEMOTHER, 13(3), 2001, pp. 309-315
33. Nagate, A; Ohyashiki, JH; Kasuga, I; Minemura, K; Abe, K; Yamamoto, K; Ohyashiki, K
    Detection and quantification of human herpesvirus 6 genomes using bronchoalveolar lavage fluid in immunocompromised patients with interstitial pneumonia
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    A. Nagate et al., "Detection and quantification of human herpesvirus 6 genomes using bronchoalveolar lavage fluid in immunocompromised patients with interstitial pneumonia", INT J MOL M, 8(4), 2001, pp. 379-383
34. Bleichert, A; Fiedler, W; Claussen, U; Ernst, G; Loncarevic, IF; Heller, A; Liehr, T; Kunert, C; Von Eggeling, F
    A long distance-PCR derived FISH probe detects a deletion between p15 and p16 in CML and T-ALL patients
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    A. Bleichert et al., "A long distance-PCR derived FISH probe detects a deletion between p15 and p16 in CML and T-ALL patients", INT J MOL M, 7(6), 2001, pp. 591-595
35. Heisterkamp, N; Voncken, JW; Senadheera, D; Hemmeryckx, B; Gonzalez-Gomez, I; Reichert, A; Pattengale, PK; Groffen, J
    The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    N. Heisterkamp et al., "The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice", INT J MOL M, 7(4), 2001, pp. 351-357
36. Sizonenko, PC; Clayton, PE; Cohen, P; Hintz, RL; Tanaka, T; Laron, Z
    Diagnosis and management of growth hormone deficiency in childhood and adolescence - Part 1: Diagnosis of growth hormone deficiency
    GROWTH HORMONE & IGF RESEARCH
    
    P.C. Sizonenko et al., "Diagnosis and management of growth hormone deficiency in childhood and adolescence - Part 1: Diagnosis of growth hormone deficiency", GROWTH H I, 11(3), 2001, pp. 137-165
37. Sklar, C; Boulad, F; Small, T; Kernan, N
    Endocrine complications of pediatric stem cell transplantation
    FRONTIERS IN BIOSCIENCE
    
    C. Sklar et al., "Endocrine complications of pediatric stem cell transplantation", FRONT BIOSC, 6, 2001, pp. G17-G22
38. Chessells, JM
    The role of bone marrow transplantation in first remission of paediatric ALL
    FRONTIERS IN BIOSCIENCE
    
    J.M. Chessells, "The role of bone marrow transplantation in first remission of paediatric ALL", FRONT BIOSC, 6, 2001, pp. G38-G42
39. Nadkarni, V; Trigg, M
    Tools for predicting risk of mortality in the ICU setting: Do we need a crystal ball or rose colored glasses?
    FRONTIERS IN BIOSCIENCE
    
    V. Nadkarni e M. Trigg, "Tools for predicting risk of mortality in the ICU setting: Do we need a crystal ball or rose colored glasses?", FRONT BIOSC, 6, 2001, pp. G43-G50
40. Sartorelli, V; Puri, PL
    The link between chromatin structure, protein acetylation and cellular differentiation
    FRONTIERS IN BIOSCIENCE
    
    V. Sartorelli e P.L. Puri, "The link between chromatin structure, protein acetylation and cellular differentiation", FRONT BIOSC, 6, 2001, pp. D1024-D1047
41. Jelic, TM; Raj, AB; Jin, B; Kurczynski, EM; Tolaymat, N; Chang, HH
    Expression of CD5 on hematogones in a 7-year-old girl with Shwachman-Diamond syndrome
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
    
    T.M. Jelic et al., "Expression of CD5 on hematogones in a 7-year-old girl with Shwachman-Diamond syndrome", PEDIATR D P, 4(5), 2001, pp. 505-511
42. Bagg, A
    Minimal residual disease: How low do we go?
    MOLECULAR DIAGNOSIS
    
    A. Bagg, "Minimal residual disease: How low do we go?", MOL DIAGN, 6(3), 2001, pp. 155-160
43. Luo, V; Lessin, SR; Wilson, RB; Rennert, H; Tozer, C; Benoit, B; Leonard, DGB
    Detection of clonal T-cell receptor gamma gene rearrangements using fluorescent-based PCR and automated high-resolution capillary electrophoresis
    MOLECULAR DIAGNOSIS
    
    V. Luo et al., "Detection of clonal T-cell receptor gamma gene rearrangements using fluorescent-based PCR and automated high-resolution capillary electrophoresis", MOL DIAGN, 6(3), 2001, pp. 169-179
44. Bartolo, C; Viswanatha, DS
    Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications
    JOURNAL OF CLINICAL LIGAND ASSAY
    
    C. Bartolo e D.S. Viswanatha, "Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications", J CLIN LIG, 24(2), 2001, pp. 76-93
45. Honda, H; Hirai, H
    Model mice for BCR/ABL-positive leukemias
    BLOOD CELLS MOLECULES AND DISEASES
    
    H. Honda e H. Hirai, "Model mice for BCR/ABL-positive leukemias", BL CELL M D, 27(1), 2001, pp. 265-278
46. Dubinsky, MC; Hassard, PV; Seidman, EG; Kam, LY; Abreu, MT; Targan, SR; Vasiliauskas, EA
    An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy
    INFLAMMATORY BOWEL DISEASES
    
    M.C. Dubinsky et al., "An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy", INFLAMM B D, 7(3), 2001, pp. 181-189
47. Cheung, IY; Cheung, NKV
    Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR
    CLINICAL CANCER RESEARCH
    
    I.Y. Cheung e N.K.V. Cheung, "Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR", CLIN CANC R, 7(6), 2001, pp. 1698-1705
48. Erickson, HA; Reinhardt, RL; Hermanson, JB; Panoskaltsis-Mortari, A; Pennell, CA
    Visualization of immunotoxin-mediated tumor cell death in vivo
    CLINICAL CANCER RESEARCH
    
    H.A. Erickson et al., "Visualization of immunotoxin-mediated tumor cell death in vivo", CLIN CANC R, 7(3), 2001, pp. 890S-894S
49. Gilliland, DG
    The diverse role of the ETS family of transcription factors in cancer - Commentary re: B. Davidson, Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin. Cancer Res., 7 : 551-557, 2001.
    CLINICAL CANCER RESEARCH
    
    D.G. Gilliland, "The diverse role of the ETS family of transcription factors in cancer - Commentary re: B. Davidson, Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin. Cancer Res., 7 : 551-557, 2001.", CLIN CANC R, 7(3), 2001, pp. 451-453
50. Whetstine, JR; Gifford, AJ; Witt, T; Liu, XY; Flatley, RM; Norris, M; Haber, M; Taub, JW; Ravindranath, Y; Matherly, LH
    Single nucleotide polymorphisms in the human reduced folate carrier: Characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers
    CLINICAL CANCER RESEARCH
    
    J.R. Whetstine et al., "Single nucleotide polymorphisms in the human reduced folate carrier: Characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers", CLIN CANC R, 7(11), 2001, pp. 3416-3422
51. Omura-Minamisawa, M; Diccianni, MB; Chang, RC; Batova, A; Bridgeman, LJ; Schiff, J; Cohn, SL; London, WB; Yu, AL
    p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease
    CLINICAL CANCER RESEARCH
    
    M. Omura-Minamisawa et al., "p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease", CLIN CANC R, 7(11), 2001, pp. 3481-3490
52. Ferguson, WS
    Exploring end-of-life care for children with cancer
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    W.S. Ferguson, "Exploring end-of-life care for children with cancer", J PED H ONC, 23(8), 2001, pp. 478-480
53. Klaassen, RJ; Doyle, JJ; Krahn, MD; Blanchette, VS; Naglie, G
    Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: Decision analysis
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    R.J. Klaassen et al., "Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: Decision analysis", J PED H ONC, 23(8), 2001, pp. 511-518
54. Felice, MS; Zubizarreta, PA; Alfaro, EM; Sackmann-Muriel, F
    Childhood acute lymphoblastic leukemia: Prognostic value of initial peripheral blast count in good responders to prednisone
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    M.S. Felice et al., "Childhood acute lymphoblastic leukemia: Prognostic value of initial peripheral blast count in good responders to prednisone", J PED H ONC, 23(7), 2001, pp. 411-415
55. Gump, J; McGavran, L; Wei, Q; Hunger, SP
    Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    J. Gump et al., "Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia", J PED H ONC, 23(7), 2001, pp. 416-419
56. Porea, TJ; Dreyer, ZE; Bricker, JT; Mahoney, DH
    Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: An outcome study
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    T.J. Porea et al., "Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: An outcome study", J PED H ONC, 23(7), 2001, pp. 420-423
57. Oeffinger, KC; Buchanan, GR; Eshelman, DA; Denke, MA; Andrews, TC; Germak, JA; Tomlinson, GE; Snell, LE; Foster, BM
    Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    K.C. Oeffinger et al., "Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia", J PED H ONC, 23(7), 2001, pp. 424-430
58. McNall, RY; Head, DR; Pui, CH; Razzouk, BI
    Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    R.Y. McNall et al., "Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy", J PED H ONC, 23(5), 2001, pp. 309-311
59. Taub, JW
    Relationship of chromosome 21 and acute leukemia in children with Down syndrome
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    J.W. Taub, "Relationship of chromosome 21 and acute leukemia in children with Down syndrome", J PED H ONC, 23(3), 2001, pp. 175-178
60. Brichard, B; Vermylen, C; Gosseye, S; Otte, JB; Cornu, G
    Smooth muscle tumor developing in an immunocompromised child after therapyfor leukemia
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    B. Brichard et al., "Smooth muscle tumor developing in an immunocompromised child after therapyfor leukemia", J PED H ONC, 23(2), 2001, pp. 139-141
61. Fukuda, M; Miyajima, Y; Miyashita, Y; Horibe, K
    Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: A pilot study
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    
    M. Fukuda et al., "Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: A pilot study", J PED H ONC, 23(1), 2001, pp. 10-13
62. Hsi, ED; Yegappan, S
    Lymphoma immunophenotyping: A new era in paraffin-section immunohistochemistry
    ADVANCES IN ANATOMIC PATHOLOGY
    
    E.D. Hsi e S. Yegappan, "Lymphoma immunophenotyping: A new era in paraffin-section immunohistochemistry", ADV ANAT PA, 8(4), 2001, pp. 218-239
63. Van Etten, RA
    Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models
    CURRENT OPINION IN HEMATOLOGY
    
    R.A. Van Etten, "Pathogenesis and treatment of Ph+ leukemia: recent insights from mouse models", CURR OPIN H, 8(4), 2001, pp. 224-230
64. McGrath, P
    Identifying support issues of parents of children with leukemia
    CANCER PRACTICE
    
    P. McGrath, "Identifying support issues of parents of children with leukemia", CANCER PRAC, 9(4), 2001, pp. 198-205
65. Scopa, CD; Vagianos, C; Kardamakis, D; Kourelis, TG; Kalofonos, HP; Tsamandas, AC
    Bcl-2-/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    C.D. Scopa et al., "Bcl-2-/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer", APPL IMMUNO, 9(4), 2001, pp. 329-334
66. Chu, PG; Arber, DA
    CD79: A review
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
    
    P.G. Chu e D.A. Arber, "CD79: A review", APPL IMMUNO, 9(2), 2001, pp. 97-106
67. Holdsworth, MT; Mathew, P
    Efficacy of colony-stimulating factors in acute leukemia
    ANNALS OF PHARMACOTHERAPY
    
    M.T. Holdsworth e P. Mathew, "Efficacy of colony-stimulating factors in acute leukemia", ANN PHARMAC, 35(1), 2001, pp. 92-108
68. Finley, RS
    Colony-stimulating factors in acute leukemia: will we ever have an answer?
    ANNALS OF PHARMACOTHERAPY
    
    R.S. Finley, "Colony-stimulating factors in acute leukemia: will we ever have an answer?", ANN PHARMAC, 35(1), 2001, pp. 120-122
69. Curtis, LJ; Dooley, MD; Lipman, EL; Feeny, DH
    The role of permanent income and family structure in the determination of child health in Canada
    HEALTH ECONOMICS
    
    L.J. Curtis et al., "The role of permanent income and family structure in the determination of child health in Canada", HEALTH ECON, 10(4), 2001, pp. 287-302
70. Bussey, KJ; Lawce, HJ; Himoe, E; Shu, XO; Heerema, NA; Perlman, EJ; Olson, SB; Magenis, RE
    SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development
    GENES CHROMOSOMES & CANCER
    
    K.J. Bussey et al., "SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development", GENE CHROM, 32(4), 2001, pp. 342-352
71. Vieira, SAD; Deininger, MWN; Sorour, A; Sinclair, P; Foroni, L; Goldman, JM; Melo, JV
    Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene
    GENES CHROMOSOMES & CANCER
    
    S.A.D. Vieira et al., "Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene", GENE CHROM, 32(4), 2001, pp. 353-363
72. Eguchi, M; Eguchi-Ishimae, M; Seto, M; Morishita, K; Suzuki, K; Ueda, R; Ueda, K; Kamada, N; Greaves, M
    GPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24)
    GENES CHROMOSOMES & CANCER
    
    M. Eguchi et al., "GPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24)", GENE CHROM, 32(3), 2001, pp. 212-221
73. Wang, YL; Bagg, A; Pear, W; Nowell, PC; Hess, JL
    Chronic myelogenous leukemia: Laboratory diagnosis and monitoring
    GENES CHROMOSOMES & CANCER
    
    Y.L. Wang et al., "Chronic myelogenous leukemia: Laboratory diagnosis and monitoring", GENE CHROM, 32(2), 2001, pp. 97-111
74. Inokuchi, K; Hamaguchi, H; Taniwaki, M; Yamaguchi, H; Tanosaki, S; Dan, K
    Establishment of a cell line with AMLI-MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemia
    GENES CHROMOSOMES & CANCER
    
    K. Inokuchi et al., "Establishment of a cell line with AMLI-MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemia", GENE CHROM, 32(2), 2001, pp. 182-187
75. Shibuya, N; Taki, T; Mugishima, H; Chin, M; Tsuchida, M; Sako, M; Kawa, K; Ishii, E; Miura, I; Yanagisawa, M; Hayashi, Y
    t(10;11)-acute leukemias with MLL-AF10 and MLL-AB11 chimeric transcripts: Specific expression patterns of AB11 gene in leukemia and solid tumor cell lines
    GENES CHROMOSOMES & CANCER
    
    N. Shibuya et al., "t(10;11)-acute leukemias with MLL-AF10 and MLL-AB11 chimeric transcripts: Specific expression patterns of AB11 gene in leukemia and solid tumor cell lines", GENE CHROM, 32(1), 2001, pp. 1-10
76. Borkhardt, A; Teigler-Schlegel, A; Fuchs, U; Keller, C; Konig, M; Harbott, J; Haas, OA
    An ins(X;11)(q24;q23) fuses the MLL and the septin 6/KIAA0128 gene in an infant with AML-M2
    GENES CHROMOSOMES & CANCER
    
    A. Borkhardt et al., "An ins(X;11)(q24;q23) fuses the MLL and the septin 6/KIAA0128 gene in an infant with AML-M2", GENE CHROM, 32(1), 2001, pp. 82-88
77. Odero, MD; Carlson, K; Calasanz, MJ; Lahortiga, I; Chinwalla, V; Rowley, JD
    Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping
    GENES CHROMOSOMES & CANCER
    
    M.D. Odero et al., "Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping", GENE CHROM, 31(2), 2001, pp. 134-142
78. Tatsumi, K; Taki, T; Taniwaki, M; Nakamura, H; Taguchi, J; Chen, YZ; Bessho, F; Yanagisawa, M; Hayashi, Y
    The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines
    GENES CHROMOSOMES & CANCER
    
    K. Tatsumi et al., "The CDCREL1 gene fused to MLL in de novo acute myeloid leukemia with t(11;22)(q23;q11.2) and its frequent expression in myeloid leukemia cell lines", GENE CHROM, 30(3), 2001, pp. 230-235
79. Van Limbergen, H; Beverloo, HB; van Drunen, E; Janssens, A; Hahlen, K; Poppe, B; Van Roy, N; Marynen, P; De Paepe, A; Slater, R; Speleman, F
    Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia
    GENES CHROMOSOMES & CANCER
    
    H. Van Limbergen et al., "Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia", GENE CHROM, 30(3), 2001, pp. 274-282
80. Petridou, E
    Is chemical pollution responsible for childhood tumors?
    EPIDEMIOLOGY
    
    E. Petridou, "Is chemical pollution responsible for childhood tumors?", EPIDEMIOLOG, 12(1), 2001, pp. 4-6
81. Infante-Rivard, C; Olson, E; Jacques, L; Ayotte, P
    Drinking water contaminants and childhood leukemia
    EPIDEMIOLOGY
    
    C. Infante-Rivard et al., "Drinking water contaminants and childhood leukemia", EPIDEMIOLOG, 12(1), 2001, pp. 13-19
82. Kebelmann-Betzing, C; Korner, G; Badiali, L; Buchwald, D; Moricke, A; Korte, A; Kochling, J; Wu, SL; Kappelmeier, D; Oettel, K; Henze, G; Seeger, K
    Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL
    CYTOKINE
    
    C. Kebelmann-Betzing et al., "Characterization of cytokine, growth factor receptor, costimulatory and adhesion molecule expression patterns of bone marrow blasts in relapsed childhood B cell precursor ALL", CYTOKINE, 13(1), 2001, pp. 39-50
83. Surico, G; Muggeo, P; Mappa, L; Muggeo, V; Conti, V; Lucarelli, A; Novielli, C; Rigillo, N
    Impairment of nasal mucociliary clearance after radiotherapy for childhoodhead cancer
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
    
    G. Surico et al., "Impairment of nasal mucociliary clearance after radiotherapy for childhoodhead cancer", HEAD NECK, 23(6), 2001, pp. 461-466
84. Rose, SR
    Cranial irradiation and central hypothyroidism
    TRENDS IN ENDOCRINOLOGY AND METABOLISM
    
    S.R. Rose, "Cranial irradiation and central hypothyroidism", TRENDS ENDO, 12(3), 2001, pp. 97-104
85. Honma, Y
    A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors
    LEUKEMIA & LYMPHOMA
    
    Y. Honma, "A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors", LEUK LYMPH, 42(5), 2001, pp. 953-962
86. Tschan, MP; Vonlanthen, S; Cajot, JF; Peters, UR; Oppliger, E; Betticher, DC; Yarbrough, WG; Fey, MF; Tobler, A
    Different p16(INK4a) and p14(ARF) expression patterns in acute myeloid leukaemia and normal blood leukocytes
    LEUKEMIA & LYMPHOMA
    
    M.P. Tschan et al., "Different p16(INK4a) and p14(ARF) expression patterns in acute myeloid leukaemia and normal blood leukocytes", LEUK LYMPH, 42(5), 2001, pp. 1077
87. Chen, CL; Rawwas, J; Sorrell, A; Eddy, L; Uckun, FM
    Bioavailability and pharmacokinetic features of etoposide in childhood acute lymphoblastic leukemia patients
    LEUKEMIA & LYMPHOMA
    
    C.L. Chen et al., "Bioavailability and pharmacokinetic features of etoposide in childhood acute lymphoblastic leukemia patients", LEUK LYMPH, 42(3), 2001, pp. 317-327
88. Nakamura, A; Tsurusawa, M; Kato, A; Taga, T; Hatae, YH; Miyake, M; Mimaya, J; Onodera, N; Watanabe, A; Watanabe, T; Kanegane, H; Matsushita, T; Iwai, A; Hyakuna, N; Gushi, K; Kawakami, T; Sekine, I; Izichi, O; Asami, K; Kikuta, AH; Tanaka, A; Fujimoto, T
    Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    A. Nakamura et al., "Prognostic impact of CD45 antigen expression in high-risk, childhood B-cell precursor acute lymphoblastic leukemia", LEUK LYMPH, 42(3), 2001, pp. 393-398
89. Yetgin, S; Yenicesu, I; Cetin, M; Tuncer, M
    Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    S. Yetgin et al., "Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia", LEUK LYMPH, 42(1-2), 2001, pp. 83-88
90. Betts, DR; Riesch, M; Grotzer, MA; Niggli, FK
    The investigation of karyotypic instability in the high-hyperdiploidy subgroup of acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    D.R. Betts et al., "The investigation of karyotypic instability in the high-hyperdiploidy subgroup of acute lymphoblastic leukemia", LEUK LYMPH, 42(1-2), 2001, pp. 187-193
91. Demirkan, F; Oztop, I; Ozsan, H; Undar, B
    Emergence of Philadelphia positive chronic myeloid leukemia in a patient with Philadelphia negative acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    F. Demirkan et al., "Emergence of Philadelphia positive chronic myeloid leukemia in a patient with Philadelphia negative acute lymphoblastic leukemia", LEUK LYMPH, 42(1-2), 2001, pp. 251-252
92. Astrom, M; Bodin, L; Tidefelt, U
    Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population
    LEUKEMIA & LYMPHOMA
    
    M. Astrom et al., "Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population", LEUK LYMPH, 41(5-6), 2001, pp. 559-570
93. Leone, G; Voso, MT; Sica, S; Morosetti, R; Pagano, L
    Therapy related leukemias: Susceptibility, prevention and treatment
    LEUKEMIA & LYMPHOMA
    
    G. Leone et al., "Therapy related leukemias: Susceptibility, prevention and treatment", LEUK LYMPH, 41(3-4), 2001, pp. 255-276
94. Cataland, SR; Daugherty, CK; Weseman, EC; Larson, RA
    Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    S.R. Cataland et al., "Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia", LEUK LYMPH, 41(3-4), 2001, pp. 297-307
95. Strickland, AH; Marsden, KA; McArdle, J; Lowenthal, RM
    Pathologic splenic rupture as the presentation of mantle cell lymphoma
    LEUKEMIA & LYMPHOMA
    
    A.H. Strickland et al., "Pathologic splenic rupture as the presentation of mantle cell lymphoma", LEUK LYMPH, 41(1-2), 2001, pp. 197
96. Mengarelli, A; Zarcone, D; Caruso, R; Tenca, C; Rana, I; Pinto, RM; Grossi, CE; De Rossi, G
    Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia
    LEUKEMIA & LYMPHOMA
    
    A. Mengarelli et al., "Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia", LEUK LYMPH, 40(5-6), 2001, pp. 625-630
97. Arima, N; Tei, CW
    HTLV-I tax related dysfunction of cell cycle regulators and oncogenesis ofadult T cell leukemia
    LEUKEMIA & LYMPHOMA
    
    N. Arima e C.W. Tei, "HTLV-I tax related dysfunction of cell cycle regulators and oncogenesis ofadult T cell leukemia", LEUK LYMPH, 40(3-4), 2001, pp. 267
98. Uckun, FM; Gaynon, PS; Stram, DO; Sensel, MG; Sarquis, MB; Willoughby, M
    Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse
    LEUKEMIA & LYMPHOMA
    
    F.M. Uckun et al., "Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse", LEUK LYMPH, 40(3-4), 2001, pp. 279-285
99. Carella, AM; Cascavilla, N; Greco, MM; Melillo, L; Sajeva, MR; Ladogana, S; D'Arena, G; Perla, G; Carotenuto, M
    Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study
    LEUKEMIA & LYMPHOMA
    
    A.M. Carella et al., "Treatment of "poor risk" acute myeloid leukemia with fludarabine, cytarabine and G-CSF (FLAG regimen): A single center study", LEUK LYMPH, 40(3-4), 2001, pp. 295-303
100. Marie, JP
     Drug resistance in hematologic malignancies
     CURRENT OPINION IN ONCOLOGY
     
     J.P. Marie, "Drug resistance in hematologic malignancies", CURR OPIN O, 13(6), 2001, pp. 463-469